- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 45.45M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.62M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.18M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.22M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.31M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $21.22M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $8.97M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $21.6M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.39M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $8.66M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $9.19M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 36.74M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.86M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $8.86M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $10.39M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.05 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $735K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.02M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.06M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $0 |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |